Section Editor: Brian G. DeRubertis, MD, FACS, Chief of the Division of Vascular and Endovascular Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical School, New York, NY
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Cardiovascular Institute of the South Press Release
Cardiovascular Institute of the South...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Department of Vascular Surgery, Army Hospital Research & Referral, New Delhi, India
Jha Manvendu, DrNB; G. Keshavamurthy,...
A 74-year-old man, who was a chronic smoker with a known case of hypertension and chronic obstructive pulmonary disease, presented with a history of breathlessness on minimal exertion.
A 74-year-old man, who was a chronic smoker with a known case of hypertension and chronic obstructive pulmonary disease, presented with a history of breathlessness on minimal exertion.
The Freesolve BTK RMS Is Designed for Patients Suffering From Chronic Limb-Threatening Ischemia (CLTI)
BÜLACH, Switzerland – March 18, 2024. BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug...
The Freesolve BTK RMS Is Designed for Patients Suffering From Chronic Limb-Threatening Ischemia (CLTI)
BÜLACH, Switzerland – March 18, 2024. BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug...
Marianne Brodmann, MD
Medical University of Graz, Graz, Austria
Marianne Brodmann, MD
Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Marianne Brodmann, MD
Medical University of Graz, Graz, Austria
Marianne Brodmann, MD
Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Alik Farber, MD
Boston Medical Center, Boston, Massachusetts
Alik Farber, MD
Boston Medical Center...
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.
Michael Lichtenberg, MD, FESC
Vascular Centre Clinic, Arnsberg, Germany
Michael Lichtenberg, MD, FESC
Vascula...
Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.
Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Dr. Anahita Dua discusses the clinical outcomes from CLARITI and PROMISE II, and how the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is changing the therapy options for patients who would otherwise need amputation.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Marianne Brodmann, MD
Medical University of Graz, Graz, Austria
Marianne Brodmann, MD
Medical Univers...
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.
Purpose: Below-knee amputation (BKA), either at the time of creation or after use, in patients with severe peripheral arterial disease (PAD) is complicated, with tissue necrosis leading t...
Purpose: In the United States, it is estimated that 6.5 million people over the age of 40 have peripheral arterial disease (PAD). Radiologists examine computed tomography angiography (CTA...
Purpose: Gold standard treatment for occlusive lesions of the common femoral artery (CFA) used to be endarterectomy. In recent years, interest for endovascular treatment of the CFA has be...
Purpose: Chronic limb-threatening ischemia has associated morbidity, mortality, and impact on quality of life. This endovascular case had a high-complexity target path anatomy with retrog...
Purpose: We report the 24-month outcomes of the PROMISE I early US feasibility study (EFS) after treatment of no-option chronic limb-threatening ischemia (CLTI) with Transcatheter Arteria...
Purpose: The purpose of this study was analysis of clinical characteristics and results of surgical revascularization in patients with acute limb ischemia (ALI) and COVID-19, compared wit...
Purpose: Acute limb ischemia (ALI) occurs with an abrupt interruption of blood flow to the extremity and a sudden decrease in limb perfusion, threatening the limb viability. The incidenc...
A. Powell, T. Maldonado, K. Nagarsheth, J. Rowse, J. Chung
A. Powell, T. Maldonado, K. Nagarshet...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: To evaluate recovery in patients with acute pulmonary embolism (PE), clinicians rely on clinical parameters and imaging. Right ventricular (RV) size and clot burden are typically evaluated using computed tomography; however,...
Purpose: To evaluate recovery in patients with acute pulmonary embolism (PE), clinicians rely on clinical parameters and imaging. Right ventricular (RV) size and clot burden are typically evaluated using computed tomography; however,...
I. Weinberg, S. Y. Dohad, W. B. Keeling, J. M. Moriarty, K. M. Sterling
I. Weinberg, S. Y. Dohad, W. B. Keeli...
Purpose: The objective of the STRIKE-PE study is to evaluate real-world long-term functional outcomes, safety, and performance of computer-aided mechanical aspiration thrombectomy with the Indigo Aspiration System (Penumbra) for the treatment...
Purpose: The objective of the STRIKE-PE study is to evaluate real-world long-term functional outcomes, safety, and performance of computer-aided mechanical aspiration thrombectomy with the Indigo Aspiration System (Penumbra) for the treatment...
Purpose: Novel technologies have shaped modern techniques in endovascular thrombectomy to ultimately improve outcomes for high-risk or critically ill patients. The purpose of our study was to examine global trends in thrombectomy device and...
Purpose: Novel technologies have shaped modern techniques in endovascular thrombectomy to ultimately improve outcomes for high-risk or critically ill patients. The purpose of our study was to examine global trends in thrombectomy device and...
Purpose: To determine if time to mechanical thrombectomy (MT) for submassive pulmonary embolism (PE) impacts length of hospital stay, 30-day readmission rate, and 30-day mortality rate.
Materials and Methods: Retrospective review of all...
Purpose: To determine if time to mechanical thrombectomy (MT) for submassive pulmonary embolism (PE) impacts length of hospital stay, 30-day readmission rate, and 30-day mortality rate.
Materials and Methods: Retrospective review of all...
Purpose: Clot in transit (CIT) is a high-risk mobile clot found in pericardiac or intracardiac locations. We examine a cohort of patients undergoing Inari device mechanical thrombectomy for known extensive thrombus as an alternative to...
Purpose: Clot in transit (CIT) is a high-risk mobile clot found in pericardiac or intracardiac locations. We examine a cohort of patients undergoing Inari device mechanical thrombectomy for known extensive thrombus as an alternative to...
Purpose: AngioJet is a versatile mechanical thrombectomy device that has a role in acute vascular presentations. In our department, we use it for venous disease, fistula salvage, and acute arterial occlusions. We hypothesize that its utility...
Purpose: AngioJet is a versatile mechanical thrombectomy device that has a role in acute vascular presentations. In our department, we use it for venous disease, fistula salvage, and acute arterial occlusions. We hypothesize that its utility...
Purpose: Pediatric deep vein thrombosis (DVT) is rare, resulting in significant morbidity caused by postthrombotic syndrome (PTS). Catheter-directed therapy (CDT) and percutaneous mechanical thrombectomy (PMT) can decrease PTS severity in...
Purpose: Pediatric deep vein thrombosis (DVT) is rare, resulting in significant morbidity caused by postthrombotic syndrome (PTS). Catheter-directed therapy (CDT) and percutaneous mechanical thrombectomy (PMT) can decrease PTS severity in...
L. Raja, A. Valles
Purpose: Limb preservation through endovascular intervention of the right upper extremity with critical limb-threatening ischemia (CLTI), Rutherford class VI with gang...
Chief Scientific & Medical Officer, American Diabetes Association, Arlington, Virginia
Presented by Robert A. Gabbay, MD, Ph...
Dr Robert Gabbay, chief scientific and medical officer of the American Diabetes Association (ADA), presented an update on the Amputation Prevention Alliance,
Dr Robert Gabbay, chief scientific and medical officer of the American Diabetes Association (ADA), presented an update on the Amputation Prevention Alliance,
Department of Surgery, University Medical Centre, Groningen, The Netherlands
Jean-Paul de Vries
Department of Sur...
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Columbia University Irving Medical Center, New York, New York
Sahil Parikh, MD
Columbia University...
Dr Parikh outlines the basis of the interest in limus devices as an alternative to paclitaxel. In his opinion, the paclitaxel mortality controversy is not a major factor here.
Dr Parikh outlines the basis of the interest in limus devices as an alternative to paclitaxel. In his opinion, the paclitaxel mortality controversy is not a major factor here.
University Heart and Vascular Center of the University Hospital, Hamburg-Eppendorf, Germany
Erwin Blessing, MD
University Heart ...
Dr Erwin Blessing spoke to LINC Today to discuss the relevant research and give his take on how intravascular lithotripsy fits into the toolbox for vessel preparation.
Dr Erwin Blessing spoke to LINC Today to discuss the relevant research and give his take on how intravascular lithotripsy fits into the toolbox for vessel preparation.
First-time data from an important study of the real-world treatment of lesions in the peripheral vasculature was previewed this afternoon by Marianne Brodmann, Head of the Division of Angiology at the Medical University of Graz, Austria.
First-time data from an important study of the real-world treatment of lesions in the peripheral vasculature was previewed this afternoon by Marianne Brodmann, Head of the Division of Angiology at the Medical University of Graz, Austria.
Presented by Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), Prince of Wales Hospital, Sydney, Australia
Written by Amanda Wright Harvey
Pres...
Dr. Ramon Varcoe presented results from SWING, a prospective, multicenter, single-arm, feasibility study that evaluated the safety and performance of the Sundance DCB in 35 patients at 8 test sites in Australia, New Zealand, and Europe.
Dr. Ramon Varcoe presented results from SWING, a prospective, multicenter, single-arm, feasibility study that evaluated the safety and performance of the Sundance DCB in 35 patients at 8 test sites in Australia, New Zealand, and Europe.
Presented by George Adams, MD MHS MBA FACC FSCAI, University of North Carolina REX Healthcare, Raleigh, North Carolina
Written by Amanda Wright Harvey
Pres...
In a session from Tuesday, George Adams, MD, MHS, MBA, FACC, FSCAI, from UNC REX Hospital in Raleigh, North Carolina, presented results from the LIBERTY 360 analysis on patients with chronic limb-threatening ischemia.
In a session from Tuesday, George Adams, MD, MHS, MBA, FACC, FSCAI, from UNC REX Hospital in Raleigh, North Carolina, presented results from the LIBERTY 360 analysis on patients with chronic limb-threatening ischemia.
Interventional radiologist Dr Bret Wiechmann presented a discussion about the importance of office-based labs and ambulatory surgery centers when treating patients with critical limb ischemia.
Interventional radiologist Dr Bret Wiechmann presented a discussion about the importance of office-based labs and ambulatory surgery centers when treating patients with critical limb ischemia.
Texas Tech University Health Sciences Center, Lubbock, Texas
Presented by Mohammad Ansari, MD
Tex...
On Thursday morning, interventional cardiologist Dr Mohammad Ansari presented late-breaking information on the clinical safety and efficacy of rotational atherectomy.
On Thursday morning, interventional cardiologist Dr Mohammad Ansari presented late-breaking information on the clinical safety and efficacy of rotational atherectomy.
Chief Scientific & Medical Officer, American Diabetes Association, Arlington, Virginia
Presented by Robert A. Gabbay, MD, Ph...
Dr Robert Gabbay, chief scientific and medical officer of the American Diabetes Association (ADA), presented an update on the Amputation Prevention Alliance,
Dr Robert Gabbay, chief scientific and medical officer of the American Diabetes Association (ADA), presented an update on the Amputation Prevention Alliance,
Houman Jalaie, MD, PhD, and Mohammad E. Barbati, MD, FEBVS
Department of Vascular Surgery, University Hospital Aachen, Germany
Houman Jalaie, MD, PhD, and Mohammad ...
This classification system can help identify optimal candidates for intervention, tailor treatment approaches, and inform patients about potential outcomes.
This classification system can help identify optimal candidates for intervention, tailor treatment approaches, and inform patients about potential outcomes.
Department of Surgery, University Medical Centre, Groningen, The Netherlands
Jean-Paul de Vries
Department of Sur...
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Cardiovascular Institute of the South Press Release
Cardiovascular Institute of the South...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
APRIL 23, 2024 - NEW IBERIA- Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Krishna Nagendran is the first in Acadiana to use the Angiodynamics Auryon Laser Atherectomy System in a hospital setting to treat...
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
The Freesolve BTK RMS Is Designed for Patients Suffering From Chronic Limb-Threatening Ischemia (CLTI)
BÜLACH, Switzerland – March 18, 2024. BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug...
The Freesolve BTK RMS Is Designed for Patients Suffering From Chronic Limb-Threatening Ischemia (CLTI)
BÜLACH, Switzerland – March 18, 2024. BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug...
Novel bioresorbable scaffold system being developed for expanded indications
LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ -- Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that the United...
Novel bioresorbable scaffold system being developed for expanded indications
LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ -- Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that the United...
Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee,...
Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee,...
ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to...
ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to...
Dr. William Gray of Lankenau Institute for Medical Research, part of Main Line Health, guided research presented at cardiology conference and published by Lancet
Wynnewood, PA — Four years ago, following a publication based on the limited...
Dr. William Gray of Lankenau Institute for Medical Research, part of Main Line Health, guided research presented at cardiology conference and published by Lancet
Wynnewood, PA — Four years ago, following a publication based on the limited...
October 23, 2023– HOUMA, LA – Cardiovascular Institute of the South (CIS) is the first in the country to use the FreedomFlow® Orbital Atherectomy Platform to treat peripheral artery disease (PAD) in the legs. Drs. Pradeep Nair, McCall Walker,...
October 23, 2023– HOUMA, LA – Cardiovascular Institute of the South (CIS) is the first in the country to use the FreedomFlow® Orbital Atherectomy Platform to treat peripheral artery disease (PAD) in the legs. Drs. Pradeep Nair, McCall Walker,...
St. Paul, MN – October 18, 2023. Cardio Flow, Inc., a privately held medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), today announced it recently received U.S. Food and Drug...
St. Paul, MN – October 18, 2023. Cardio Flow, Inc., a privately held medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), today announced it recently received U.S. Food and Drug...
First Patient Enrolled in RCT comparing BIOTRONIK’s scaffold to a contemporary drug-eluting stent (DES)
BUELACH, Switzerland -- May 13, 2024 -- BIOTRONIK announced today the enrollment of the first patient in the BIOMAG-II trial...
First Patient Enrolled in RCT comparing BIOTRONIK’s scaffold to a contemporary drug-eluting stent (DES)
BUELACH, Switzerland -- May 13, 2024 -- BIOTRONIK announced today the enrollment of the first patient in the BIOMAG-II trial...
The prospective, single-arm, multicenter study will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in the infrapopliteal arteries below the knee. A novel device intended for use in patients with...
The prospective, single-arm, multicenter study will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in the infrapopliteal arteries below the knee. A novel device intended for use in patients with...
Siemens Healthineers and University Hospitals Cleveland News
Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot burden
LATHAM, N.Y.--(BUSINESS WIRE)--May...
New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot burden
LATHAM, N.Y.--(BUSINESS WIRE)--May...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization
SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
To inform heart team and patient decision-making on valve surgery, The Society of Thoracic Surgeons (STS) has launched new risk calculators for isolated tricuspid valve repair and replacement; surgical aortic valve replacement (SAVR) after...
To inform heart team and patient decision-making on valve surgery, The Society of Thoracic Surgeons (STS) has launched new risk calculators for isolated tricuspid valve repair and replacement; surgical aortic valve replacement (SAVR) after...
"The FDA approval of Abbott's Esprit BTK System marks a significant milestone in our fight against peripheral artery disease below the knee and should usher in a new era of improved outcomes for people worldwide," said Sahil A. Parikh, M.D.,...
"The FDA approval of Abbott's Esprit BTK System marks a significant milestone in our fight against peripheral artery disease below the knee and should usher in a new era of improved outcomes for people worldwide," said Sahil A. Parikh, M.D.,...
Groundbreaking technology for the precise, automatic measurement of peripheral blood vessels to optimize treatment strategies
SAN DIEGO, April 25, 2024 /PRNewswire/ -- Provisio Medical today announced FDA 510(k) clearance of the Provisio™...
Groundbreaking technology for the precise, automatic measurement of peripheral blood vessels to optimize treatment strategies
SAN DIEGO, April 25, 2024 /PRNewswire/ -- Provisio Medical today announced FDA 510(k) clearance of the Provisio™...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...